Literature DB >> 3582405

Relevance of vesico-ureteric reflux in development of lipid A antibodies in recurrent urinary tract infections in children--a preliminary study.

P J Mar, W Marget, K Schneider, B H Belohradsky, R Roos.   

Abstract

The serum titres of IgG and IgM antibodies to lipid A were measured in 24 children with chronic pyelonephritis (PN), 55 with recurrent lower urinary tract infections (LUTI), 13 with gram-negative sepsis (S), and in 50 control children using an enzyme-linked immunosorbent assay (ELISA). Children ranged in age from 1 month-17 years. Patients with PN were differentiated by the presence or absence of an acute infectious episode and/or vesico-ureteric reflux (VUR). During an acute episode in PN and LUTI, IgG titres were significantly higher than in controls, but only PN patients with an acute infectious episode also had significantly elevated IgM titres. Overall, children with LUTI showed a significantly lower frequency of detectable IgG lipid A antibodies (27%) than in PN (63%). In PN children with VUR not accompanied by an infectious episode, lipid A antibody was found at relatively low titres, while an episode not accompanied by VUR displayed significantly elevated IgG titres, and an episode accompanied by VUR showed elevation of both IgG and IgM anti-lipid A antibody titres.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582405     DOI: 10.1007/bf00647284

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

Review 1.  Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture.

Authors:  O Westphal
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children.

Authors:  D Edwards; I C Normand; N Prescod; J M Smellie
Journal:  Br Med J       Date:  1977-07-30

3.  The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule.

Authors:  M A Freudenberg; B Kleine; C Galanos
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

4.  [Occurence, significance and clinical consequences of lipid A antibody titers in patients with urinary tract infection (author's transl)].

Authors:  M Westenfelder; C Galanos; A Withöft; G Lang
Journal:  Infection       Date:  1977       Impact factor: 3.553

5.  Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux.

Authors:  J A Roberts; G M Suarez; B Kaack; G Kallenius; S B Svenson
Journal:  J Urol       Date:  1985-06       Impact factor: 7.450

6.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

7.  Antibodies to lipid A during urinary tract infection.

Authors:  I Mattsby-Baltzer; I Claësson; L A Hanson; U Jodal; B Kaijser; U Lindberg; H Peterson
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

8.  Radionuclide cystography: the significance of retention time of the refluxed radioisotope.

Authors:  I Nissenkorn; I Gil; C Servadio; E Lubin
Journal:  J Urol       Date:  1981-10       Impact factor: 7.450

9.  Lipid A antibody determinations using ELISA on patients at a children's hospital: a preliminary report.

Authors:  W Marget; M Weiss; B Ruhland
Journal:  Infection       Date:  1983 Mar-Apr       Impact factor: 3.553

10.  Immunogenic properties of lipid A.

Authors:  C Galanos; M A Freudenberg; F Jay; D Nerkar; K Veleva; H Brade; W Strittmatter
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug
View more
  4 in total

1.  The last round against bacterial infections?

Authors:  W Marget
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

2.  [Lipoid A antibody titer in the human].

Authors:  W Marget
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

3.  [Lipoid A antibody titer in humans].

Authors:  W Marget
Journal:  Infection       Date:  1987       Impact factor: 3.553

4.  Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.

Authors:  G Kronborg; A Fomsgaard; C Galanos; M A Freudenberg; N Høiby
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.